Splitting tablets

Australian Prescriber

Volumn 25, Issue 6, 2002, Pages

  Marriott, Jennifer L ^a   Nation, Roger L ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Compliance; Dosing; Quality use of medicines

Indexed keywords

ACARBOSE; AGON SR; ALENDRONIC ACID; AMILORIDE; AURANOFIN; AZATHIOPRINE; BENZATROPINE MESILATE; CEFACLOR; CLOZAPINE; D PENAMINE; DIAFORMIN; DICLOFENAC; DIGOXIN; DONEPEZIL; FELODIPINE; FINASTERIDE; FOSINOPRIL; KSR; LAMOTRIGINE; LANOXIN PG; MESALAZINE; METFORMIN; NIFECARD; NIFEDIPINE; PANTOPRAZOLE; PENICILLAMINE; POTASSIUM CHLORIDE; SELEGILINE; TAMOXIFEN CITRATE; TEMAZE; TEMAZEPAM; TILUDRONIC ACID; TRAMADOL; TRAMAL SR; TRYPTOPHAN; VALPROIC ACID;

ACCURACY; ARTICLE; DRUG DEGRADATION; DRUG DOSE REDUCTION; DRUG QUALITY; DRUG SOLUBILITY; PATIENT COMPLIANCE; TABLET; TABLET FORMULATION;

EID: 0036919388     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2002.131     Document Type: Article

References (7)

1. McDevitt JT, Gurst AH, Chen Y. Accuracy of tablet splitting. Pharmacotherapy 1998;18:193-7.
2. Mandal TK. Effect of tablet integrity on the dissolution rate of sustained-release preparations. J Clin Pharm Ther 1996;21:155-7.
3. Carr-Lopez SM, Mallett MS, Morse T. The tablet splitter: Barrier to compliance or cost-saving instrument? Am J Health Syst Pharm 1995;52:2707-8.
4. Horn LW, Kuhn RJ, Kanga JF. Evaluation of the reproducibility of tablet splitting to provide accurate doses for the pediatric population. J Pediatr Pharm Pract 1999;4:38-42.
5. Atkin PA, Finnegan TP, Ogle SJ, Shenfield GM. Functional ability of patients to manage medication packaging: A survey of geriatric inpatients. Age Ageing 1994;23:113-6.
6. Fawell NG, Cookson TL, Scranton SS. Relationship between tablet splitting and compliance, drug acquisition cost, and patient acceptance. Am J Health Syst Pharm 1999;56:2542-5.
7. Rindone JP. Evaluation of tablet-splitting in patients taking lisinopril for hypertension. J Clin Outcomes Manage 2000;7:22-4.